Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.



Digital Health Spotlight Series: The Clinical Foundations of Effective Digital Care

2021/01/21 13:00:00
2021/01/21 14:00:00

January 21, 2021

1:00 PM - 2:00 PMAmerica/New_York

    About this Webinar

    The demand for telehealth and digital care solutions has grown exponentially throughout 2020 - a trend that won’t recede, even as the pandemic eventually comes to an end. Patients are increasingly relying on connected devices, wraparound virtual services, and social support structures to address chronic conditions like diabetes, hypertension, and mental health. But even as individuals, health plans, and employers have adopted these solutions rapidly by necessity, the time has come to evaluate them rigorously. This evaluation process includes an examination of everything from user experience to implementation ease--but above all--demanding the same clinical validation as any other medical benefit.

    For this session, Advisory Board’s Andrew Rebhan will be presenting with Sean Duffy, CEO at Omada Health, to share how health care stakeholders can leverage digital tools and human support to create lasting behavior change, while also demanding the highest levels of clinical rigor in product development and clinical validation.

    Things You’ll Learn:

    • How to determine a digital health solution’s credibility amidst a rapidly evolving landscape
    • Key questions to ask when weighing “snake oil” solutions versus an effective program of high clinical quality
    • How proper investment in clinical studies, randomized controlled trials, and real-world claims analyses can help to constantly refine digital health products, and optimize them for user experience and key outcomes

    Log in to access this webinar

    Log in

    Don't have an account? Learn about membership benefits

    Have a Question?


    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.